Arkolith/Insider Trading/PRLD/Form 4

Chardonnet Laurent

Chief Financial OfficerPrelude Therapeutics Inc (PRLD) · full profile →Form 4 · filed Mar 4, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 1, 2024Grant(A)150K—$0150K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-24-002135) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML